Published in Am J Clin Pathol on October 01, 1997
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. J Transl Med (2009) 1.35
New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J Clin Pathol (2002) 0.85
Practical approach to management of chronic lymphocytic leukemia. Arch Med Sci (2015) 0.80
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial. Br J Haematol (2016) 0.80
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. Mod Pathol (2015) 0.79
A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia. PLoS One (2011) 0.79
The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Mod Pathol (2016) 0.78
Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality. Clin Med Insights Pathol (2014) 0.78
Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry. J Clin Pathol (2002) 0.77
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity. Cytometry B Clin Cytom (2010) 0.76
Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms. Arch Pathol Lab Med (2014) 0.76
Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia. Contemp Oncol (Pozn) (2014) 0.76
Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia. Rev Bras Hematol Hemoter (2016) 0.75
Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry. Hematol Rep (2012) 0.75
Flow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia. Adv Hematol (2010) 0.75
Lymphoma without Lymphadenopathy. Chin Med J (Engl) (2015) 0.75
Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges. Rev Bras Hematol Hemoter (2016) 0.75
A population-based assessment of the prognostic value of the CD19 positive lymphocyte count in B-cell chronic lymphocytic leukemia using Cox and Markov models. Eur J Epidemiol (2005) 0.75
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia (1995) 4.04
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet (1990) 2.77
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
Natural history of stage IV epithelial ovarian cancer. J Clin Oncol (1999) 2.52
A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol (1992) 2.33
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol (1998) 2.21
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol (1994) 2.20
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia (1994) 2.11
Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type. Am J Surg Pathol (1995) 2.09
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood (1991) 1.79
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol (1996) 1.78
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses (1988) 1.74
Mouse red-cell rosettes in B-lymphoproliferative disorders. Br J Haematol (1976) 1.72
Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67
Prolymphocytic leukaemia. Br J Haematol (1974) 1.66
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol (1980) 1.63
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol (1989) 1.62
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (1989) 1.59
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. J Clin Oncol (1997) 1.57
Influence of cholecystectomy on symptoms. Br J Surg (1991) 1.54
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck. Ann Oncol (1997) 1.53
The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol (1991) 1.53
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood (1990) 1.53
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol (1994) 1.53
The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol (1986) 1.52
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res (1983) 1.48
Co-trimoxazole for prevention of infection in acute leukaemia. Lancet (1978) 1.47
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet (1990) 1.47
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol (1986) 1.47
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. Proc Natl Acad Sci U S A (1982) 1.47
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol (2002) 1.46
Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood (1998) 1.46
Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ (1991) 1.46
T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders. Clin Exp Immunol (1979) 1.46
Outcome of biphenotypic acute leukemia. Haematologica (1999) 1.46
Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med (1978) 1.46
Chronic myelomonocytic leukaemia. Br J Haematol (1975) 1.45
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol (1995) 1.43
The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T-cell leukaemias. Br J Haematol (1990) 1.41
Central nervous system involvement demonstrated by immunological study in prolymphocytic variant of chronic lymphocytic leukemia. Acta Haematol (1989) 1.41
Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood (1997) 1.41
Mammographic accuracy and patient age: a study of 297 patients undergoing breast biopsy. Clin Radiol (1993) 1.40
Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol (1987) 1.40
Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet (1984) 1.38
Definition of acute biphenotypic leukemia. Haematologica (1997) 1.37
The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol (1989) 1.35
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet (1997) 1.32
Phenotypic heterogeneity and cellular origins of T cell malignancies. Leuk Res (1981) 1.32
Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol (1977) 1.31
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. J Hosp Infect (1984) 1.31
The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol (1994) 1.30
Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet (1977) 1.30
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Clin Cancer Res (1999) 1.29
The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol (2003) 1.29
The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer (1990) 1.28
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood (2001) 1.27
The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis. Br J Haematol (1974) 1.27
Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet (1974) 1.26
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk Res (1998) 1.25
Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962-1987. Int J Radiat Oncol Biol Phys (1990) 1.25
Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. Br J Haematol (2004) 1.24
Thromboembolic complications in myelomatosis. Br Med J (1970) 1.23
Prolymphocytic leukaemia of B and T cell type. Lancet (1973) 1.23
Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg (2000) 1.23
Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol (1974) 1.22
Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases. Br J Haematol (1976) 1.22
The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood (1994) 1.19
Hypokalaemia and raised lysozyme levels in acute myeloid leukaemia. Q J Med (1973) 1.18